Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.

Guidance Documents/Guidance-Document/Acromegaly: Developing Drugs for Treatment

Acromegaly: Developing Drugs for Treatment

Detailed guidance document from FDA and regulatory agencies.

Document Details

Document Type

Guidance Document

Issue Date

January 30, 2023

Office

Center for Drug Evaluation and Research

Document ID

943da437-2f18-40af-a375-bbe3e2bde11f

Related Documents

Data Standards Catalog

Guidance DocumentMarch 24, 2025

View Details →

Head Lice Infestation: Developing Drugs for Topical Treatment Guidance for Industry

Guidance DocumentOctober 5, 2016

View Details →

Antidepressant Drugs--Clinical Evaluation

Guidance DocumentSeptember 1, 1977

View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.

Regulatory Data Transformed

Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

info@globalkeysolutions.net

Quick Links

Home Platform Overview Media

KeyPedia™ Lite

Browse Hub Database Directory Records Companies Offices People Careers About Us Founding Team Meet Our Experts Partners

Legal & Ethics

Privacy Policy Terms of Service Our Values & Mission Code of Ethics & AI Policy

©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.

Acromegaly: Developing Drugs for Treatment - FDA Guidance Document | KeyPedia